Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Beijing Double-Crane Pharmaceutical Co. Ltd.

www.dcpc.com

Latest From Beijing Double-Crane Pharmaceutical Co. Ltd.

China Fast-Tracks Multiple HCV Drugs With Access In Mind

All eyes on a list of selected oral hepatitis C drugs that are expected to win out in China's notoriously lengthy approval battle, amid a potentially huge opening as Chinese HCV patients switch from interferon to all oral therapies.

BioPharmaceutical China

Asia On The Move: New CFDA Directors, AZ China GM

The China FDA has appointed several key directors and UK drug maker AstraZeneca has quietly changed its China head to a locally grown executive. Personnel changes also take place in major domestic maker Hisun, the China State Administration for Industry and Commerce (SAIC), Acucela and AdvaMed.

BioPharmaceutical Medical Device

WuXi’s New Unit Joins Race For Drug Innovation In China

WuXi is opening up its service platform, manufacturing capacity and pockets, aiming to develop global biotech innovations in China faster and cost-effectively. The strategy may draw on a template of a joint venture with MedImmune and a contract manufacturing deal for Ambrx already in place.

BioPharmaceutical China

WuXi’s New Unit Joins Race For Drug Innovation In China

WuXi is opening up its service platform, manufacturing capacity and pockets, aiming to develop global innovations in China faster and cost-effectively. The strategy may draw on a template of a joint venture with MedImmune and a contract manufacturing deal for Ambrx already in place.

BioPharmaceutical China
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cardiovascular
  • Infectious & Viral Diseases
  • Metabolic Disorders
  • Alias(es)
  • Double-Crane
  • DCPC
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • China
  • Parent & Subsidiaries
  • Beijing Double-Crane Pharmaceutical Co. Ltd.
  • Senior Management
  • Xin Li, Pres.
  • Contact Info
  • Beijing Double-Crane Pharmaceutical Co. Ltd.
    Phone: (86) 10 6474 2227
    1 WanJing Lize East 2 Rd.
    Chaoyang Dist.
    Beijing, 100102
    China
Advertisement
Advertisement
UsernamePublicRestriction

Register